Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Difficult to Control Hypertension: early-phase trial registry

1 of 1 indexed Difficult to Control Hypertension trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Difficult to Control Hypertension: 1 US clinical trial tracked, 1 recruiting.

Difficult to Control Hypertension is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is E-Star BioTech, running 1 of these trials.

Enrollment posture brief

Registry condition difficult-to-control-hypertension

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Difficult to Control Hyp (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Difficult to Control Hypertension

Difficult to Control Hypertension lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Difficult to Control Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Difficult to Control Hypertension is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

E-Star BioTech 1 trials

Named interventions

Most-linked intervention names on Difficult to Control Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Matched control Other
1 trials
MANP Drug
1 trials

US sites by state

Facility locations filed on Difficult to Control Hypertension trials. A trial with sites in several states counts in each.

Ohio 1 trials
North Carolina 1 trials
Michigan 1 trials
Illinois 1 trials
Georgia 1 trials
Florida 1 trials
California 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Difficult to Control Hypertension page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Difficult to Control Hypertension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • E-Star BioTech sponsors the most Difficult to Control Hypertension trials on record, review their full trial history before evaluating a specific study. See E-Star BioTech's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Difficult to Control Hypertension condition card totals 1 registered trials; most-linked intervention Placebo Matched control; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.